肝细胞癌门静脉癌栓免疫微环境的单细胞分辨率特征
本研究通过飞行时间质谱流式、单细胞RNA测序及多重荧光免疫组化等技术,揭示肝细胞癌门静脉癌栓(PVTT)中以巨噬细胞和单核细胞为主导的免疫抑制微环境。PVTT中TAM-C5AR1为最常见亚群(36.7%),C5aR+ TAM/Mφ富集且与C5a正相关,可抑制CD8+ T细胞颗粒酶B,高浸润与低分化、总生存差及术后PVTT再形成相关。
要点
- PVTT中巨噬/单核细胞占比54.1%,高于原发瘤26.3%和血9.1%(p<0.05)。
- TAM-C5AR1为PVTT最常见亚群(36.7%),C5aR+ TAM/Mφ富集且与C5a正相关(r=0.559,p<0.001)。
- C5aR+ TAM高浸润与低分化(p<0.009)、总生存(p=0.003)及术后PVTT再形成(p=0.007)相关。
核心结论
- TAMs尤其是C5aR+ TAMs在PVTT中富集,通过重塑免疫抑制环境促进PVTT进展和不良预后。
研究设计与样本
- 采用飞行时间质谱流式、单细胞RNA测序、多重荧光免疫组化及细胞实验探索PVTT免疫微环境。
主要发现
- PVTT中巨噬细胞和单核细胞占54.1%,高于原发瘤26.3%和血9.1%(p<0.05)。
- PVTT中抑制性和调节性免疫细胞差异富集,提示免疫抑制环境。
- TAM-C5AR1以白细胞趋化为特征,为PVTT最常见亚群(36.7%)。
- C5aR+ TAM/Mφ在PVTT中较原发瘤和肝富集,与C5a正相关(r=0.559,p<0.001)。
- CSQT2可招募THP-1并上调CD163、CD206、PD-L1,C5aR拮抗剂可逆转;C5aR+ TAMs抑制CD8+ T细胞颗粒酶B。
关键数值与推荐
- PVTT中巨噬/单核细胞占比54.1%,原发瘤26.3%,血9.1%(p<0.05)。
- TAM-C5AR1占PVTT亚群36.7%。
- C5aR+ TAM/Mφ与C5a正相关(r=0.559,p<0.001)。
- C5aR+ TAMs高浸润与低分化(p<0.009)、总生存(p=0.003)、术后PVTT再形成(p=0.007)相关。
临床怎么用
- PVTT免疫微环境以C5aR+ TAMs为关键抑制性亚群,可作为潜在干预靶点。
- C5aR+ TAMs高浸润提示低分化和不良预后,或有助于风险分层。
- C5aR拮抗剂在体外可逆转单核细胞向抑制性表型转化,支持进一步临床转化研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Portal vein tumor thrombus (PVTT) worsens the prognosis of hepatocellular carcinoma by increasing intrahepatic dissemination and inducing portal vein hypertension. However, the immune characteristics of PVTT remain unclear. Therefore, this study aims to explore the immune microenvironment in PVTT. APPROACH AND RESULTS: Time-of-flight mass cytometry revealed that macrophages and monocytes were the dominant immune cell type in PVTT, with a higher proportion than in primary tumor and blood (54.1% vs. 26.3% and 9.1%, p<0.05). The differentially enriched clustering of inhibitory and regulatory immune cells in PVTT indicated an immune-suppressive environment. According to the single-cell RNA sequencing, TAM-C5AR1 was characterized by leukocyte chemotaxis and was the most common subpopulation in PVTT (36.7%). Multiplex fluorescent immunohistochemistry staining showed that the C5aR+ TAM/Mφ were enriched in PVTT compared to both the primary tumor and liver and positively correlated with C5a (r=0.559, p<0.001). Notably, THP-1 (monocyte cell line) was recruited by CSQT2 (PVTT cell line) and exhibited up-regulation of CD163, CD206, and PD-L1 upon stimulation. C5aR antagonist could reverse this. C5aR+ TAMs could also inhibit Granzyme B in CD8+ T cells. High infiltration of C5aR+ TAMs in PVTT correlated with poor differentiation (p<0.009) and was a risk factor for overall survival (p=0.003) and for reformation of PVTT after resection (p=0.007). CONCLUSIONS: TAMs, especially C5aR+ TAMs, were enriched in PVTT. C5aR+ TAMs contribute to the development of PVTT and poor prognosis by reshaping the immunosuppressive environment.
引用
- Zhou KQ, Zhong YC, Song MF, et al. Distinct immune microenvironment of venous tumor thrombus in hepatocellular carcinoma at single-cell resolution. Hepatology. 2024. PMID: 40833994. doi:10.1097/HEP.0000000000001182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。